Vaccin - activities

Covid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en France

Covid: would we have to get yearly booster shot against the virus?

Would Covid seasonality have us get yearly booster shot, like we do against the flu? A question INSERM scientist and infectious disease specialist Odile Launay tried to answer to this Monday March 1 on LCI.
Vaccin contre la Covid : c'est quoi, l'ARN messager ?Vaccin contre la Covid : c'est quoi, l'ARN messager ?Vaccin contre la Covid : c'est quoi, l'ARN messager ?Vaccin contre la Covid : c'est quoi, l'ARN messager ?

AstraZeneca vaccine particularly effective in people aged 65+, a Scottish study finds

Is AstraZeneca vaccine effective against severe Covid in elderly people? This is what a study carried out by the Edinburgh and Glasgow universities found, only available in preprint and currently studied to be published. If approved by a scientific committee, this observation could be a game changer for the French vaccination strategy.
Coronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai cliniqueCoronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai cliniqueCoronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai cliniqueCoronavirus : le vaccin allemand de chez CureVac désormais en deuxième phase d'essai clinique

Covid: Janssen vaccine to arrive in May, with one month delay

The Health Minister has announced Janssen Covid vaccine – aka Johnson & Johnson subsidiary – will arrive in France later than expected, in May 2021 instead of April. A vaccine still waiting to be approved by the European Medicines Agency.
Covid : le laboratoire Merck abandonne les essais sur son candidat vaccinCovid : le laboratoire Merck abandonne les essais sur son candidat vaccinCovid : le laboratoire Merck abandonne les essais sur son candidat vaccinCovid : le laboratoire Merck abandonne les essais sur son candidat vaccin

Covid: vaccines effective from the first shot, a Scottish study finds

According to a wide study carried out in Scotland, Covid vaccines developed by Pfizer and AstraZeneca dramatically decrease risk of severe Covid from the first shot.
Vaccin contre le coronavirus : 30 millions de personnes seront prioritaires selon le Conseil scientifiqueVaccin contre le coronavirus : 30 millions de personnes seront prioritaires selon le Conseil scientifiqueVaccin contre le coronavirus : 30 millions de personnes seront prioritaires selon le Conseil scientifiqueVaccin contre le coronavirus : 30 millions de personnes seront prioritaires selon le Conseil scientifique

Covid vaccine: new diseases added to the list of people given priority for vaccination

Who should be prioritized for Covid-19 vaccines? A question the Haute Autorité de Santé is expected to officially answer to this Monday November 30, along with guidelines as for France’s vaccine strategy. The list of people given priority is extended as vaccines arrive, including - starting Wednesday March 3, 2021 - people suffering from mental disorders, among others. Keep reading to find out more!
Vaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur CaumesVaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur CaumesVaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur CaumesVaccin Pfizer : un niveau inquiétant d'effets indésirables selon le professeur Caumes

AstraZeneca vaccine now approved in France for people aged 65-74

After being recommended this past February 10 by WHO for people aged 65+, AstraZeneca vaccine has also been approved in France for people between the age of 65 and 75. This is what Olivier Véran announced on Monday March 1, 2021 on France 2, during an interview.
Covid : l'injection des premières doses de vaccin reportée dans plusieurs régionsCovid : l'injection des premières doses de vaccin reportée dans plusieurs régionsCovid : l'injection des premières doses de vaccin reportée dans plusieurs régionsCovid : l'injection des premières doses de vaccin reportée dans plusieurs régions

Covid: Macron wishes to send 4 to 5% of wealthy countries’ vaccines to Africa

As part of the G7, French President Emmanuel Macron said he would like to support Africa and proposed to transfer 4 to 5% of Covid vaccines ordered by wealthy countries to Africa, namely 13 million doses. An idea supported by German Chancellor Angela Merkel.
Vaccin : les pays de l’UE seront livrés comme prévu au premier trimestre, assure PfizerVaccin : les pays de l’UE seront livrés comme prévu au premier trimestre, assure PfizerVaccin : les pays de l’UE seront livrés comme prévu au premier trimestre, assure PfizerVaccin : les pays de l’UE seront livrés comme prévu au premier trimestre, assure Pfizer

Covid: one dose of vaccine is said to be enough for people who have been already infected by the virus

In a report given to the government this Friday February 12, the French Haute Autorité de Santé has stated that people who have been already infected by Covid will only get one, and only one, dose of vaccine, for those given the Pfizer or Moderna vaccines. The reason? These people – who have been infected already – have then already develop antibodies and only one injection is said to protect them as much, and even more than those given two doses if they have not been infected before.
Covid : le laboratoire Merck abandonne les essais sur son candidat vaccinCovid : le laboratoire Merck abandonne les essais sur son candidat vaccinCovid : le laboratoire Merck abandonne les essais sur son candidat vaccinCovid : le laboratoire Merck abandonne les essais sur son candidat vaccin

AstraZeneca vaccine: enhanced vigilance after adverse effects reported in 149 health workers

AstraZeneca vaccine subject to worries… This Thursday February 11, the ANSM said that in 10,000 health workers vaccinated, 149 of them developed mild but harsh side effects such as fever, headache and flu-like condition. Adverse effects required for some to call in sick.
Visuel Musée d'Art Moderne de ParisVisuel Musée d'Art Moderne de ParisVisuel Musée d'Art Moderne de ParisVisuel Musée d'Art Moderne de Paris

Covid: Roselyne Bachelot wants no vaccine passport to enjoy cultural places

As the government is trying to reopen museums soon, Roselyne Bachelot has stood out against instating a vaccine passport for people to enjoy cultural places.
Vaccin contre la Covid : le produit de Moderna protégerait pendant trois moisVaccin contre la Covid : le produit de Moderna protégerait pendant trois moisVaccin contre la Covid : le produit de Moderna protégerait pendant trois moisVaccin contre la Covid : le produit de Moderna protégerait pendant trois mois

Covid: who and when can one get a vaccine?

Despite the details of the mass Covid vaccine campaign and the different steps explained by Jean Castex and Olivier Véran a few weeks ago, you still do not know which group you belong to? What step you are part of? How to know if you can get a vaccine? Here are answers.
Vaccin contre la Covid : les retards dans les campagnes pourraient coûter des milliards à l'EuropeVaccin contre la Covid : les retards dans les campagnes pourraient coûter des milliards à l'EuropeVaccin contre la Covid : les retards dans les campagnes pourraient coûter des milliards à l'EuropeVaccin contre la Covid : les retards dans les campagnes pourraient coûter des milliards à l'Europe

Covid vaccine: delayed vaccination campaign could cost Europe billions

Delayed vaccination campaign within the European Union could cost billions to the 27… According to Euler Hermès experts’ calculations, it could cost between 100 million and 3 billion depending on the countries and per week of lockdown, for a total that could reach up to 90 billion euros for 2021.
Visuel ParisVisuel ParisVisuel ParisVisuel Paris

Jean Castex’s press briefing: no lockdown at this stage

Prime Minister Jean Castex held a press briefing this Thursday February 4, 2021 to address the health crisis in France. According to the government, the current situation does not justify another lockdown to face the coronavirus epidemic.
Coronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageantsCoronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageantsCoronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageantsCoronavirus : le vaccin d'Ose Immunotherapeutics donnent des résultats encourageants

Vaccine: vaccine manufacturing, new appointments... the latest governmental announcements

As part of a press brief held this Thursday February 4, 2021, Jean Castex and his ministers addressed the ongoing vaccine campaign widely detailed this January 5 by Health Minister Olivier Véran. New appointments to get the first dose, vaccine supply in France... Here is more on the matter!
Coronavirus : le vaccin russe a montré des résultats encourageantsCoronavirus : le vaccin russe a montré des résultats encourageantsCoronavirus : le vaccin russe a montré des résultats encourageantsCoronavirus : le vaccin russe a montré des résultats encourageants

Covid-19: Russian vaccine Sputnik V is 91.6% effective, The Lancet says

As in November 2020 results of the Russian Covid vaccine Sputnik V sparked many doubts given the lack of transparency and as they cut corners in the development of the vaccine, this Tuesday February 2, independent experts released their own assessment in The Lancet. Good news: Sputnik V is 91.6% effective - and not 95% as previously announced. The vaccine is waiting for approval from the European Union to be authorized for marketing very soon.
Covid : un vaccin pour lutter contre les variants développé par GSK et CureVac pour bientôtCovid : un vaccin pour lutter contre les variants développé par GSK et CureVac pour bientôtCovid : un vaccin pour lutter contre les variants développé par GSK et CureVac pour bientôtCovid : un vaccin pour lutter contre les variants développé par GSK et CureVac pour bientôt

Covid: variant vaccine developed by GSK and CureVac soon to be available

Laboratories GSK and CureVac have announced they are working together to fight against Covid variants, more transmissible and potentially resisting against products currently available on the market. Vaccine may be authorized for marketing in 2022.
Covid : le vaccin d'AstraZeneca réduirait la transmission du virus selon une étudeCovid : le vaccin d'AstraZeneca réduirait la transmission du virus selon une étudeCovid : le vaccin d'AstraZeneca réduirait la transmission du virus selon une étudeCovid : le vaccin d'AstraZeneca réduirait la transmission du virus selon une étude

Covid: AstraZeneca to reduce virus spread – a study says

According to a study led by the Oxford University, AstraZeneca Covid vaccine reduces by 67% the spread of the virus from the first dose injected. Good news in the fight against the pandemic and eventually the eradication of the disease.
Covid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en FranceCovid : le vaccin de Moderna bientôt produit en France

Covid: Moderna vaccine soon to be manufactured in France

This Wednesday February 3, Deputy Minister for Industry Agnès Pannier-Runacher announced that in addition to deliveries scheduled already, Moderna Covid vaccine will be manufactured in France by a subcontractor. Production is to start “in March”.
Coronavirus : le vaccin russe soupçonné de fraude ?Coronavirus : le vaccin russe soupçonné de fraude ?Coronavirus : le vaccin russe soupçonné de fraude ?Coronavirus : le vaccin russe soupçonné de fraude ?

Covid: AstraZeneca vaccine approved by France's Haute Autorité de Santé for people under 65

Appproved by the European Medicines Agency since this Friday January 29, Covid vaccine by AstraZeneca has been approved, this Tuesday February 2, by the Haute Autorité de Santé only for people under the age of 65. It is to arrive in France from February 8 - according to Secretary of State for European Affairs Clément Beaune.
Covid-19 : un autre vaccin sur le point d'être annoncé selon  Anthony FauciCovid-19 : un autre vaccin sur le point d'être annoncé selon  Anthony FauciCovid-19 : un autre vaccin sur le point d'être annoncé selon  Anthony FauciCovid-19 : un autre vaccin sur le point d'être annoncé selon  Anthony Fauci

Covid: Johnson & Johnson vaccine 66% effective the laboratory says

Good news in the search against Covid! Johnson & Johnson announced this Friday January 29 in a release that their vaccine against coronavirus was overall 66% effective, and between 85% and 100% in preventing severe disease 28 and 49 days after the injection.